TDAC Shareholders Approve Extension, Redemptions Successful
TDAC is trading near its 52-week low of $10 (7.3% above the low).
Summary
Translational Development Acquisition Corp. announced successful share redemption results in connection with its extension vote. This follows the preliminary and definitive proxy statements filed in May seeking shareholder approval to extend the business combination deadline. The 'successful' outcome indicates that the extension vote likely passed, allowing TDAC to proceed with its previously announced definitive merger agreement with ProLogium Holding Inc. The specific redemption numbers, which will be critical for assessing the remaining cash in trust for the merger, are expected to be disclosed in an upcoming filing.
At the time of this announcement, TDAC was trading at $10.73 on NASDAQ in the Finance sector, with a market capitalization of approximately $235.5M. The 52-week trading range was $10.00 to $15.18. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.